Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $2.44 down -3.94% from its previous closing price of $2.54. In other words, the price has decreased by -$3.94 from its previous closing price. On the day, 2.09 million shares were traded. ALLO stock price reached its highest trading level at $2.58 during the session, while it also had its lowest trading level at $2.44.
Ratios:
For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.25 and its Current Ratio is at 12.25. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 21 ’24 when Parker Geoffrey M. bought 36,404 shares for $2.84 per share.
Douglas Earl Martin bought 28,310 shares of ALLO for $78,844 on Aug 21 ’24. On Jun 18 ’24, another insider, MESSEMER DEBORAH M., who serves as the Director of the company, sold 18,641 shares for $2.28 each. As a result, the insider received 42,488 and left with 166,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 579238912 and an Enterprise Value of 159814096. For the stock, the TTM Price-to-Sale (P/S) ratio is 5669.20 while its Price-to-Book (P/B) ratio in mrq is 0.99. Its current Enterprise Value per Revenue stands at 2458.678 whereas that against EBITDA is -0.623.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -9.05%, while the 200-Day Moving Average is calculated to be -23.65%.
Shares Statistics:
For the past three months, ALLO has traded an average of 1.81M shares per day and 1644320 over the past ten days. A total of 167.13M shares are outstanding, with a floating share count of 138.03M. Insiders hold about 33.99% of the company’s shares, while institutions hold 66.84% stake in the company. Shares short for ALLO as of 1728950400 were 39318504 with a Short Ratio of 21.72, compared to 1726185600 on 39187976. Therefore, it implies a Short% of Shares Outstanding of 39318504 and a Short% of Float of 26.47.
